LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2015 |
| Author/s |
author: Richard M Bergenstal John Buse |
| Publication date | February 23, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |